scholarly journals Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼

2018 ◽  
Vol 29 ◽  
pp. vii52
Author(s):  
Chikara Ogawa ◽  
Masahiro Morita ◽  
Akina Omura ◽  
Mitsushige Shibatoge ◽  
Akemi Tsutsui ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Advanced Hepatocellular Carcinoma ◽  
Predictor Factor

785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY

2009 ◽  
Vol 50 ◽  
pp. S287 ◽  
Author(s):  
S. Del Prete ◽  
R. Addeo ◽  
M. Caraglia ◽  
L. Maiorino ◽  
V. Montesarchio ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Advanced Hepatocellular Carcinoma

scholarly journals A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

2016 ◽  
Vol 23 (10) ◽  
pp. 2405-2413 ◽  
Author(s):  
Thomas C.C. Yau ◽  
Riccardo Lencioni ◽  
Wattana Sukeepaisarnjaroen ◽  
Yee Chao ◽  
Chia-Jui Yen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Multicenter Study ◽  
Single Agent ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Gemcitabine plus oxaliplatin (GemOx) in advanced hepatocellular carcinoma (HCC): A multicenter study of over 200 patients.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4033-4033
Author(s):  
N. Williet ◽  
A. Zaanan ◽  
M. Hebbar ◽  
V. Boige ◽  
L. Fartoux ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Advanced Hepatocellular Carcinoma

Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.

2021 ◽  
Author(s):  
Giovanni Marasco ◽  
Antonio Colecchia ◽  
Maria Letizia Bacchi Reggiani ◽  
Ciro Celsa ◽  
Fabio Farinati ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Prognostic Models ◽  
Advanced Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document